Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens-Reference-Cited by-同舟云学术

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens

Published:2014-03-06 Issue:10 Volume:123 Page:1615-1620
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Bitan Menachem¹,He Wensheng²,Zhang Mei-Jie³,Abdel-Azim Hisham⁴⁵,Ayas Mouhab Fakhreddine⁶,Bielorai Bella⁷,Carpenter Paul A.⁸,Cairo Mitchell S.⁹,Diaz Miguel Angel¹⁰,Horan John T.¹¹,Jodele Sonata¹²,Kitko Carrie L.¹³,Schultz Kirk R.¹⁴,Kletzel Morris¹⁵,Kasow Kimberly A.¹⁶,Lehmann Leslie E.¹⁷,Mehta Parinda A.¹²,Shah Nirali¹⁸,Pulsipher Michael A.¹⁹,Prestidge Tim²⁰,Seber Adriana²¹,Shenoy Shalini²²,Woolfrey Ann E.⁸,Yu Lolie C.²³,Davies Stella M.¹²

Affiliation:

1. Department of Pediatric Hematology/Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel;

2. Center for International Blood and Marrow Transplant Research, Department of Medicine, and

3. Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI;

4. Division of Hematology/Oncology and Blood Marrow Transplant/Research Immunology, Children’s Hospital Los Angeles, CA;

5. Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA;

6. Department of Pediatric Hematology Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia;

7. Department of Pediatric Hematology-Oncology & BMT, Sheba Medical Center, Tel-Hashomer, Israel;

8. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

9. Department of Pediatrics, New York Medical College, Valhalla, NY;

10. Unidad de Trasplante Hematopoyético, Hospital Niño Jesús, Madrid, Spain;

11. Pediatric Hematology/Oncology, Children’s Healthcare of Atlanta at Egleston, Atlanta, GA;

12. Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH;

13. Pediatrics and Communicable Diseases Blood and Marrow Transplant Program, The University of Michigan, Ann Arbor, MI;

14. Pediatric Hematology/Oncology, British Columbia’s Children’s Hospital, Vancouver, British Columbia, Canada;

15. Pediatrics-Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL;

16. Division of Pediatric Hematology/Oncology, University of North Carolina Hospitals, Chapel Hill, NC;

17. Pediatric Stem Cell Transplant Unit, Dana-Farber Cancer Institute, Boston, MA;

18. Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD;

19. Primary Children’s Medical Center, Division of Hematology/Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT;

20. Paediatric Haematology/Oncology, Starship Children’s Hospital, Auckland, New Zealand;

21. Bone Marrow Transplantation, Instituto de Oncologia Pediatrica, Sao Paulo, Brazil;

22. Pediatric Stem Cell Transplant Program, Washington University, St. Louis Children’s Hospital, St. Louis, MO; and

23. Division of Hematology/Oncology, Louisiana State University Children’s Hospital, New Orleans, LA

Abstract

Key Points Reduced intensity and myeloablative regimen results in comparable survival after allogeneic transplantation.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/10/1615/1374936/1615.pdf

Reference24 articles.

1. A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.;Niewerth;Blood,2010

2. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival.;Neudorf;Blood,2004

3. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?—an American view.;Chen;Br J Haematol,2002

4. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?—a European view.;Creutzig;Br J Haematol,2002

5. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.;Baker;Pediatr Clin North Am,2010

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of survival after hematopoietic stem cell transplantation and trends at a pediatric transplantation center; a three‐decade journey;Pediatric Transplantation;2024-01-26

2. Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study;Bone Marrow Transplantation;2024-01-15

3. Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia;Cancers;2023-08-18

4. Allogeneic Transplantation of Hematopoietic Stem Cells (HSCs) for Acute Leukemia in Children – Review of Literature and Experience of Single Center in Russia;Leukemia - From Biology to Clinic;2023-03-01

5. Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia;Frontiers in Pediatrics;2023-02-17